Please use this identifier to cite or link to this item: 10.36141/svdld.v41i2.15156
Title: Osteoporotic Bone Fracture Risk Assessment in Latvian Patients with Newly Diagnosed Sarcoidosis
Authors: Ruza, Ieva
Lucane, Zane
Vanaga, Elina
Persana, Marta
Vitenberga-Verza, Zane
Strumfa, Ilze
Department of Internal Diseases
Department of Pathology
Keywords: bone;bone fracture risk;calcium;fracture risk assessment;fractures;hypercalcaemia;hypercalciuria;osteoporosis;sarcoidosis;vitamin D;3.2 Clinical medicine;3.1 Basic medicine;1.1. Scientific article indexed in Web of Science and/or Scopus database;Internal Medicine;Immunology and Allergy;Pulmonary and Respiratory Medicine
Issue Date: 28-Jun-2024
Citation: Ruza , I , Lucane , Z , Vanaga , E , Persana , M , Vitenberga-Verza , Z & Strumfa , I 2024 , ' Osteoporotic Bone Fracture Risk Assessment in Latvian Patients with Newly Diagnosed Sarcoidosis ' , Sarcoidosis Vasculitis and Diffuse Lung Diseases , vol. 41 , no. 2 , e2024020 , pp. 1-8 . https://doi.org/10.36141/svdld.v41i2.15156
Abstract: Background and aim: Increased calcitriol synthesis in sarcoid granulomas with subsequent hypercalcaemia and hypercalciuria can affect bone metabolism in patients with sarcoidosis. Multiple factors can increase the fracture risk in patients with sarcoidosis. This study aimed to evaluate a 10-year osteoporotic and a 10-year hip fracture risk and to analyse factors affecting fracture risk for patients with newly diagnosed sarcoidosis compared to an age- and gender-matched control group from a real-world setting. Methods: The cross-sectional study included 171 patients with a histologically verified diagnosis of sarcoidosis who were hospitalised due to suspected sarcoidosis within two years and an age- and gender-matched control group of 178 hospitalised individuals. QFracture algorithm questions were asked during interviews. Results: A cohort of 349 subjects was analysed. The median age in the patient group was 40 years (IQR:20), and 60.2% were female. 21.6% of patients with sarcoidosis had at least one comorbidity that could potentially influence the osteoporotic fracture risk. Both the median 10-year osteoporotic fracture risk (0.9% (IQR:2) vs 1.3% (IQR:2.3), p=0.005; U=12394) and a 10-year hip fracture risk (0.1% (IQR:0.3) vs 0.2% (IQR:0.5), p=0.003; U=12368.5) was lower in patients with sarcoidosis compared to control group subjects. As compared to the control group, individuals with sarcoidosis exhibited a lower frequency of both osteoporotic (2.4% vs 11.2%, OR=0.189 (95% CI:0.063-0.566), p=0.003) and low-energy trauma fractures (2.9% vs 11.8%, OR=0.225 (95% CI:0.083-0.612), p=0.003) in personal medical history. Conclusions: This was the first study to investigate osteoporotic fracture risk and related factors in Latvian patients with newly diagnosed sarcoidosis. Our data show a lower risk of a 10-year osteoporotic and a 10-year hip fracture risk in patients with sarcoidosis compared to age- and gender-matched control group subjects from a real-world setting.
Description: Publisher Copyright: © Mattioli 1885.
DOI: 10.36141/svdld.v41i2.15156
ISSN: 1124-0490
Appears in Collections:Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure

Files in This Item:
File SizeFormat 
Osteoporotic_bone_fracture_risk_assessment.pdf151.33 kBAdobe PDFView/Openopen_acces_unlocked


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.